top of page
>
>
Process overhaul at a Top 5 pharma
Client Problems
- After a large merger, there was a need to align R&D portfolio data systems, investment valuation methodologies, and data processes
- Need for a flexible data system and processes that could handle asset valuations for portfolio decision making, 1-off BD valuation scenarios, and global assumptions instead of U.S.-only
What We Did
- Led cross-functional internal team to assess discrepancies between buying firm and acquired firm
- Identified process, methodology, and data system improvements (fit to purpose, with goal of improving quality of inputs for decision making while avoiding excessive process)
- Built internal buy-in with executives to upgrade portfolio data systems, conduct roll-out workshops to build employee user buy-in, and implement methodological upgrades
Our Results And Insight
- The improved process, data system upgrades, and methodologies were approved by the portfolio decision making executives
- The data system and processes remain in place today as a highly-functioning portfolio management solution
See other case studies
Portfolio Management case studies >
Service Areas Details
Portfolio Management
Therapeutic Areas Details
N/A
Featured Consultants
bottom of page